Feasibility of Partners in Care Program for Caregivers of Patients With Acute Myeloid Leukemia
NCT ID: NCT03806192
Last Updated: 2021-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
12 participants
INTERVENTIONAL
2019-03-16
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
NCT01519596
Patient Ambassador Support in Newly Diagnosed Patients With Acute Leukemia During Treatment
NCT03493906
Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue
NCT03747757
Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia
NCT00056069
Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
NCT00321880
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
GROUP A: Participants attend 5 psychoeducational counseling sessions over 30-60 minutes via telephone.
GROUP B: Participants attend 5 psychoeducational counseling sessions over 30-60 minutes via video teleconference.
After completion of study, participants are followed up at 4 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A (psychoeducational counseling sessions via telephone)
Participants attend 5 psychoeducational counseling sessions over 30-60 minutes via telephone.
Telephone-Based Intervention
Attend psychoeducational counseling sessions via telephone
Questionnaire Administration
Ancillary studies
Group B (psychoeducational counseling sessions in person)
Participants attend 5 psychoeducational counseling sessions over 30-60 minutes via video teleconference.
Behavioral, Psychological or Informational Intervention
Attend psychoeducational counseling sessions via video teleconference
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telephone-Based Intervention
Attend psychoeducational counseling sessions via telephone
Behavioral, Psychological or Informational Intervention
Attend psychoeducational counseling sessions via video teleconference
Questionnaire Administration
Ancillary studies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Caregivers and patients need to write, read, and speak English as one of their languages of choice; and currently sharing a residence at least 50% of the time together
* Patient must have no other concurrent cancer diagnosis except for basal or squamous cell
* Caregiver must be able to sustain up to 60 minutes of interaction with patient educator
* Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria
* The patient cannot have another concurrent cancer diagnosis except for basal or squamous cell
* Caregiver cannot sustain up to 60 minutes of interaction with the patient educator
* Caregiver does not have access to a computer with 2-way video capability (i.e. ZOOM) or a cell phone
18 Years
82 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frances Lewis
Role: PRINCIPAL_INVESTIGATOR
Fred Hutch/University of Washington Cancer Consortium
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2018-03629
Identifier Type: REGISTRY
Identifier Source: secondary_id
10048
Identifier Type: OTHER
Identifier Source: secondary_id
RG1003619
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.